Karl Storz   Report issue

For profit Phase 3
Founded: Tuttlingen Germany (1945)
Status: No NME R&D (1945)

Organization Overview

First Clinical Trial
2006
NCT00285701
First Marketed Drug
1955
tetracycline (tetrex)
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Dr. Te Vuong | KARL STORZ Endoscopy-America, Inc. | STORZ